Dr. Ali Dawood | Medicine and Dentistry | Best Researcher Award

Assist. Prof at Infectious Disease Mathematical Modelling, University of Mosul, Iraq

Professional Profiles:

• Scopus Profile
• ORCID Profile

🎓 Education:

• Ph.D. in Microbiology, College of Science, University of Mosul, 2015.
• M.Sc. in Biotechnology, Faculty of Bioscience and Bioengineering, University Technology Malaysia, 2011.
• B.Sc. in Microbiology, Dept. of Biology, College of Science, University of Mosul, 1989.

📚 Training Courses:

• IC3 computer test (880), 2011.
• Extensive English course-sem.2 (2007-2008), University Technology Malaysia.
• Certificate of ITP TOEFL (score 473), August 2011.
• Certificate of Achieving Foreign Language, College of Arts, Mosul University, 1991.

💌 Thankful Letters:

• Minister of Higher Education and Scientific Research.
• President of University of Mosul.
• Dean of College of Medicine, Mosul University (2006, 2008, 2012).

👨‍🏫 Professional Posts:

• Assist. Prof, College of Medicine, Uni. Of Mosul from 2021 till now. Dept. of Anatomy Rapporteur from 1/7/2021.
• Lecturer, College of Medicine, Uni. Of Mosul from 2015 till now.
• Lecturer, College of Dentistry, Uni. Of Mosul 2015-2016.
• Associate lecturer, College of Medicine, Uni. of Mosul from 2011 till 2014.
• Associate researcher, College of Medicine, Uni. Of Mosul from 2005-2009 and 1993-1994.
• Course Unit Director, College of Medicine, Uni. of Mosul from 2020 till now.

👩‍🔬 Professional Experiences:

• Teaching virology lessons for 3rd class medical students, Universities of Mosul and Nineveh 2015-2016.
• Teaching Medical Biology lessons for the first class medicine and dentistry students, University of Mosul from 2011.
• Working in Medical Laboratories.
• Teaching the scientific and laboratory lessons for the first class students in Medical Biology, Colleges of Medicine.
• Member of Iraqi Biologists Union since 1990.

Publications:

1. Uneven Expression of 20 Human Papillomavirus Genes Associated with Oropharyngeal Carcinoma
   • Author: A.A. Dawood
   • Citations: 0
   • Year: 2023
2. CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), the next medical revolution against cancer | CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), la siguiente revolución médica contra el cáncer
   • Author: A.A. Dawood
   • Citations: 0
   • Year: 2023
3. The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between Mpro and antiviral drugs (nirmatrelvir and ritonavir)
   • Author: A.A. Dawood
   • Citations: 4
   • Year: 2023
4. Simulate the agarose gel of the receptor binding domain in Omicron’s spike protein inserted into the pGEM®-T Easy vector using SpeI and SacI restriction enzymes
   • Author: A.A. Dawood
   • Citations: 0
   • Year: 2023
5. Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein | Determinación de la afinidad de unión de la tunicamicina con las proteínas del SARS-CoV-2: proteinasa, proteasa, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envolvente y RBD de la glicoproteína Spike
   • Author: A.A. Dawood
   • Citations: 0
   • Year: 2023
6. Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants | Implementación de enfoques inmunoquimioinformáticos para construir múltiples epítopos para la vacuna contra las variantes Omicron y Delta SARS-CoV-2
   • Author: A.A. Dawood
   • Citations: 2
   • Year: 2022
7. Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence
   • Author: A.A. Dawood
   • Citations: 14
   • Year: 2022